PNOC017: BGB-290 with Temozolomide in Adolescent and Young Adult IDH1/2 ND and Recurrent Glioma

Study Details

Full Title

A Target Validation/Phase1 Study of BGB-290 in Combination with Temozolomide in
Adolescent and Young Adult IDH1/2 Newly Diagnosed and Recurrent Mutant Gliomas

Principal Investigator

Daniel
Landi

Protocol Number

PRO00111760

NCT ID

NCT03749187

Phase

I

Enrollment Status

Open to Enrollment
ClinicalTrials.gov